Vicarious Surgical (RBOT) Cash & Current Investments (2020 - 2025)
Vicarious Surgical (RBOT) posted quarterly Cash & Current Investments of $15.0 million for Q4 2025, down 81.06% year-over-year from $79.4 million in Q4 2024, and down 36.44% quarter-over-quarter from $23.7 million in Q3 2025.
Vicarious Surgical (RBOT) Cash & Current Investments (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has reported Cash & Current Investments for 6 consecutive years, with $15.0 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Cash & Current Investments fell 81.06% year-over-year to $15.0 million; the TTM figure through Dec 2025 stood at $15.0 million (down 81.06% YoY), while the FY2025 annual figure was $15.0 million, down 81.06% from the prior year.
- Cash & Current Investments eased to $15.0 million in Q4 2025 per RBOT's latest filing, from $23.7 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $186.0 million in Q3 2023 and bottomed at $1.0 million in Q1 2021.
- Historically, Cash & Current Investments has averaged $98.3 million across 5 years, with a median of $107.3 million in 2023.
- Annual changes were most pronounced in 2022 — Cash & Current Investments surged 15173.98% — and 2025, when it tumbled 81.06%.
- Vicarious Surgical's Cash & Current Investments stood at $173.5 million in 2021, then sank by 33.02% to $116.2 million in 2022, then advanced by 5.16% to $122.2 million in 2023, then slumped by 35.0% to $79.4 million in 2024, then sank by 81.06% to $15.0 million in 2025.
- Business Quant data shows RBOT's Cash & Current Investments at $15.0 million in Q4 2025, $23.7 million in Q3 2025, and $44.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 3.48 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 4.25 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 1.95 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 3.32 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Vicarious Surgical | 196,495.36 | -14.84 Mn | - | 15.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 15.04 Mn |
| Sep 30, 2025 | 23.66 Mn |
| Jun 30, 2025 | 44.02 Mn |
| Mar 31, 2025 | 72.13 Mn |
| Dec 31, 2024 | 79.43 Mn |
| Sep 30, 2024 | 114.66 Mn |
| Jun 30, 2024 | 73.23 Mn |
| Mar 31, 2024 | 130.03 Mn |
| Dec 31, 2023 | 122.20 Mn |
| Sep 30, 2023 | 185.99 Mn |
| Jun 30, 2023 | 99.95 Mn |
| Mar 31, 2023 | 97.57 Mn |
| Dec 31, 2022 | 116.21 Mn |
| Sep 30, 2022 | 126.80 Mn |
| Jun 30, 2022 | 141.32 Mn |
| Mar 31, 2022 | 157.01 Mn |
| Dec 31, 2021 | 173.51 Mn |
| Sep 30, 2021 | 185.05 Mn |
| Jun 30, 2021 | 7.71 Mn |
| Mar 31, 2021 | 1.03 Mn |